LifeSemantics Corp. (347700) - Net Assets
Based on the latest financial reports, LifeSemantics Corp. (347700) has net assets worth ₩102.38 Billion KRW (≈ $69.38 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩511.23 Billion ≈ $346.45 Million USD) and total liabilities (₩408.85 Billion ≈ $277.07 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 347700 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩102.38 Billion |
| % of Total Assets | 20.03% |
| Annual Growth Rate | N/A |
| 5-Year Change | 387.3% |
| 10-Year Change | N/A |
| Growth Volatility | 360.78 |
LifeSemantics Corp. - Net Assets Trend (2017–2025)
This chart illustrates how LifeSemantics Corp.'s net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of LifeSemantics Corp. to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for LifeSemantics Corp. (2017–2025)
The table below shows the annual net assets of LifeSemantics Corp. from 2017 to 2025. For live valuation and market cap data, see LifeSemantics Corp. market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩63.63 Billion ≈ $43.12 Million |
+103.62% |
| 2024-12-31 | ₩31.25 Billion ≈ $21.18 Million |
+248.19% |
| 2023-12-31 | ₩8.98 Billion ≈ $6.08 Million |
-6.23% |
| 2022-12-31 | ₩9.57 Billion ≈ $6.49 Million |
-26.70% |
| 2021-12-31 | ₩13.06 Billion ≈ $8.85 Million |
+497.39% |
| 2020-12-31 | ₩2.19 Billion ≈ $1.48 Million |
+161.96% |
| 2019-12-31 | ₩-3.53 Billion ≈ $-2.39 Million |
-680.83% |
| 2018-12-31 | ₩607.35 Million ≈ $411.59K |
+133.07% |
| 2017-12-31 | ₩-1.84 Billion ≈ $-1.24 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to LifeSemantics Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1833112310000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩11.71 Billion | 18.40% |
| Other Components | ₩51.92 Billion | 81.60% |
| Total Equity | ₩63.63 Billion | 100.00% |
LifeSemantics Corp. Competitors by Market Cap
The table below lists competitors of LifeSemantics Corp. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shandong Xinhua Pharmaceutical Co Ltd
SHE:000756
|
$865.20 Million |
|
Cisen Pharmaceutical Co Ltd
SHG:603367
|
$865.25 Million |
|
SG Fleet Group Ltd
AU:SGF
|
$865.28 Million |
|
JOST Werke AG
XETRA:JST
|
$865.39 Million |
|
Fujian Longma Envi Sanitation
SHG:603686
|
$865.05 Million |
|
Kelsian Group Ltd
AU:KLS
|
$864.96 Million |
|
Center Laboratories
TWO:4123
|
$864.88 Million |
|
Shanghai Yongguan Adhesive Products Corp Ltd
SHG:603681
|
$864.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LifeSemantics Corp.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 31,251,297,400 to 63,634,142,970, a change of 32,382,845,570 (103.6%).
- Net income of 170,261,020 contributed positively to equity growth.
- Share repurchases of 54,381,040 reduced equity.
- New share issuances of 102,579,240 increased equity.
- Other factors increased equity by 32,164,386,350.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩170.26 Million | +0.27% |
| Share Repurchases | ₩54.38 Million | -0.09% |
| Share Issuances | ₩102.58 Million | +0.16% |
| Other Changes | ₩32.16 Billion | +50.55% |
| Total Change | ₩- | 103.62% |
Book Value vs Market Value Analysis
This analysis compares LifeSemantics Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 15.12x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩-187.83 | ₩27150.00 | x |
| 2018-12-31 | ₩62.12 | ₩27150.00 | x |
| 2019-12-31 | ₩-360.82 | ₩27150.00 | x |
| 2020-12-31 | ₩249.91 | ₩27150.00 | x |
| 2021-12-31 | ₩1154.04 | ₩27150.00 | x |
| 2022-12-31 | ₩836.91 | ₩27150.00 | x |
| 2023-12-31 | ₩572.97 | ₩27150.00 | x |
| 2024-12-31 | ₩1417.93 | ₩27150.00 | x |
| 2025-12-31 | ₩1795.90 | ₩27150.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LifeSemantics Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.27%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.18%
- • Asset Turnover: 1.00x
- • Equity Multiplier: 1.50x
- Recent ROE (0.27%) is above the historical average (-144.32%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.00% | 73.03% | 0.84x | 0.00x | ₩1.94 Billion |
| 2018 | -609.17% | -535.39% | 0.08x | 13.51x | ₩-3.76 Billion |
| 2019 | 0.00% | -341.09% | 0.19x | 0.00x | ₩-3.61 Billion |
| 2020 | -425.85% | -349.24% | 0.28x | 4.36x | ₩-9.53 Billion |
| 2021 | -47.60% | -134.12% | 0.14x | 2.55x | ₩-7.52 Billion |
| 2022 | -34.99% | -118.80% | 0.11x | 2.73x | ₩-4.31 Billion |
| 2023 | -125.50% | -682.07% | 0.09x | 2.12x | ₩-12.16 Billion |
| 2024 | -56.00% | -684.25% | 0.06x | 1.43x | ₩-20.63 Billion |
| 2025 | 0.27% | 0.18% | 1.00x | 1.50x | ₩-6.19 Billion |
Industry Comparison
This section compares LifeSemantics Corp.'s net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $52,044,661,590
- Average return on equity (ROE) among peers: 2.89%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LifeSemantics Corp. (347700) | ₩102.38 Billion | 0.00% | 3.99x | $865.11 Million |
| BIT Computer Co. Ltd (032850) | $39.90 Billion | 10.43% | 0.31x | $43.61 Million |
| ezCaretech Co. LTD (099750) | $28.68 Billion | 12.34% | 0.37x | $126.44 Million |
| SyntekaBio Inc (226330) | $41.54 Billion | -15.62% | 0.08x | $22.54 Million |
| Carelabs Co.Ltd (263700) | $98.05 Billion | 4.42% | 0.35x | $26.49 Million |
About LifeSemantics Corp.
Sphere Corp. provides digital healthcare technology, and life care products and services. It develops LifeRecord, a commercial personal health record platform that manages health-related data, including medical records, genome data, and personally generated health data. The company also offers digital healthcare services for consumers, such as non-face-to-face treatment, medication management, an… Read more